MedTrace Logo

Additional Hyperbaric Oxygen After Lower Extremity Amputation

NCT03594344 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-03-30

No results posted yet for this study

Summary

This study evaluates the effect of additional hyperbaric oxygen therapy after lower extremity amputation. The patients will be randomized after amputation to either a treatment group receiving hyperbaric oxygen therapy, or control group.

Conditions

  • Diabetes Mellitus
  • Claudication, Intermittent
  • Critical Limb Ischemia
  • Osteomyelitis
  • Amputation
  • Lower Extremity Ulcer
  • Diabetic Angiopathy
  • Diabetic Neuropathies
  • Diabetic Foot

Interventions

PROCEDURE

Hyperbaric oxygen therapy

Breathing 100% oxygen for 30+30+30 min at 2,4 ATA. in a multiplace hyperbaric chamber. Total of 30 sessions

Sponsors & Collaborators

  • Diakonhjemmet Hospital

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Jonas V Rydinge, MD · Ullevål University Hospital, orthopedic department

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-04
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03594344 on ClinicalTrials.gov